Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does LEVONORGESTREL Cause Pulmonary embolism? 119 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 119 reports of Pulmonary embolism have been filed in association with LEVONORGESTREL (Mirena). This represents 0.1% of all adverse event reports for LEVONORGESTREL.

119
Reports of Pulmonary embolism with LEVONORGESTREL
0.1%
of all LEVONORGESTREL reports
6
Deaths
65
Hospitalizations

How Dangerous Is Pulmonary embolism From LEVONORGESTREL?

Of the 119 reports, 6 (5.0%) resulted in death, 65 (54.6%) required hospitalization, and 24 (20.2%) were considered life-threatening.

Is Pulmonary embolism Listed in the Official Label?

Yes, Pulmonary embolism is listed as a known adverse reaction in the official FDA drug label for LEVONORGESTREL.

What Other Side Effects Does LEVONORGESTREL Cause?

Device expulsion (27,572) Device dislocation (13,757) Vaginal haemorrhage (10,910) Genital haemorrhage (7,968) Drug ineffective (6,008) Abdominal pain lower (5,938) Procedural pain (5,572) Uterine perforation (4,973) Nausea (4,879) Complication of device insertion (4,662)

What Other Drugs Cause Pulmonary embolism?

RIVAROXABAN (3,282) LENALIDOMIDE (2,976) APIXABAN (2,714) ETHINYL ESTRADIOL\ETONOGESTREL (2,370) TESTOSTERONE (2,043) RITUXIMAB (1,764) ADALIMUMAB (1,663) PREDNISONE (1,586) METHOTREXATE (1,508) DEXAMETHASONE (1,336)

Which LEVONORGESTREL Alternatives Have Lower Pulmonary embolism Risk?

LEVONORGESTREL vs LEVORPHANOL LEVONORGESTREL vs LEVOSIMENDAN LEVONORGESTREL vs LEVOSULPIRIDE LEVONORGESTREL vs LEVOTHYROXINE LEVONORGESTREL vs LEVOTHYROXINE\LEVOTHYROXINE

Related Pages

LEVONORGESTREL Full Profile All Pulmonary embolism Reports All Drugs Causing Pulmonary embolism LEVONORGESTREL Demographics